XII Medical - About the company
XII Medical is a series B company based in United States, founded in 2021 by Garrett Schwab. It operates as a Developer of a device for the treatment of obstructive sleep apnea. XII Medical has raised $75M in funding from investors like Broadview Ventures, Ajax Health and Omega Funds. The company has 22 active competitors, including 6 funded and 2 that have exited. Its top competitors include companies like Nyxoah, Respicardia and Somnair Sleep.
Company Details
Developer of a device for the treatment of obstructive sleep apnea. The company's technology develops a minimally invasive neurostimulation device to alleviate sleep apnea and increases oropharyngeal airflow.
- Website
- xiimedical.com
- Email ID
- *****@xiimedical.com
Key Metrics
Founded Year
2021
Location
Stage
Series B
Total Funding
$75M in 2 rounds
Latest Funding Round
Investors
Ranked
3rd among 22 active competitors
Employee Count
39 as on Aug 31, 2026
Sign up to download XII Medical's company profile
XII Medical's funding and investors
XII Medical has raised a total funding of $75M over 2 rounds. Its first funding round was on Apr 29, 2022. Its latest funding round was a Series B round on Aug 20, 2024 for $*****. 7 investors participated in its latest round. XII Medical has 11 institutional investors.
Here is the list of recent funding rounds of XII Medical:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Aug 20, 2024 | 7665623 | Series B | 7931911 | 3142008 | 2234445 | 2668527 |
Apr 29, 2022 | 8890812 | Series A | 6132048 | 4315007 |
Access funding benchmarks and valuations. Sign up today!View details of XII Medical's funding rounds and investors
XII Medical's founders and board of directors
Founder? Claim ProfileThe founders of XII Medical is Garrett Schwab. Garrett Schwab is the CEO of XII Medical.
Here are the details of XII Medical's key team members:
- Garrett Schwab: CEO of XII Medical. Contact Info: 1 email address
View details of XII Medical's Founder profiles and Board Members
XII Medical's employee count trend
XII Medical has 39 employees as of Aug 26. Here is XII Medical's employee count trend over the years:
Uncover XII Medical's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
XII Medical's Competitors and alternates
Top competitors of XII Medical include Nyxoah, Respicardia and Somnair Sleep. Here is the list of Top 10 competitors of XII Medical, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Provider of a neurostimulation device for obstructive sleep apnea treatments | $88.7M | 62/100 | ||
2nd | Respicardia 2006, Minnetonka (United States), Acquired | Manufacturing implantable stimulation device to improve cardiovascular health by restoring natural breathing at night | $185M | 52/100 | |
3rd |  XII Medical 2021, United States, Series B | Developer of a device for the treatment of obstructive sleep apnea | $75M | 46/100 | |
4th |  Somnair Sleep 2024, Baltimore (United States), Series A | Developer of a non-invasive neurostimulation device for obstructive sleep apnea | $4.32M | - | 34/100 |
5th | Siesta Medical 2009, Los Gatos (United States), Seed | Provider of minimally invasive sleep apnea treatment systems. It offers a quick, safe, and lasting treatment to unblock the airway, improving sleep quality without the need for masks or machines. The system is designed for patient comfort and quick recovery, and is adjustable and reversible. The treatment is as effective as more complex surgeries but at a lower cost. The company also provides resources and support materials for both patients and healthcare providers. | $1.93M | - | 34/100 |
6th |  M.I. Cloud Tech 2021, Singapore (Singapore), Unfunded | Provider of magnetic interference cloud technology to develop solutions for healthcare, food technology, and green technology industries | - | - | 31/100 |
7th |  Lunair Minneapolis (United States), Series A | Developer of an implantable neurostimulation device for moderate-to-severe sleep apnea | $7.5M | 30/100 | |
8th |  Restora Medical 2023, Irvine (United States), Series B | Developer of restorative sleep apnea therapy using targeted nerve stimulation | $21M | - | 30/100 |
9th |  Brain Electrophysiology Laboratory 1980, Eugene (United States), Funding Raised | Provider of neuroscience technologies for sleep management | - | 28/100 | |
10th |  Zeus 2022, United Kingdom, Seed | Developer of a non-invasive anti-snoring device | $199K | 27/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on XII Medical's competitors? Click here to see the top ones
XII Medical's Investments and acquisitions
XII Medical has made no investments or acquisitions yet.
Reports related to XII Medical
Here is the latest report on XII Medical's sector:
News related to XII Medical
•
Xii medical raises $45 million in series b financing to advance best-in-class neuromodulation therapy for obstructive sleep apneaPR Newswire•Aug 21, 2024•XII Medical, Omega Funds, Intuitive, Cleveland Clinic and 4 others
•
XII Medical Completes $30 Million Series A FinancingPR Newswire•May 05, 2022•XII Medical, Broadview Ventures, Cleveland Clinic, Aperture Venture Partners and 4 others
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about XII Medical
Explore our recently published companies
- Knot Knot Games - Unfunded company
- Inteacc Softech - Vaughan based, 1995 founded, Unfunded company
- Instituto Junguiano da Bahia - Salvador based, 1993 founded, Unfunded company
- Kabar Malang - Malang based, Unfunded company
- Mascot - Engesvang based, Unfunded company
- Immo-Pro - Wavre based, 2005 founded, Unfunded company
